MRTX — Mirati Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for Mirati Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	223	415	1,390	1,491	1,084
Net Total Accounts Receivable
Net Total Receivables	0.768	1.57	2.3	2.51	3.73
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	227	424	1,404	1,508	1,109
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.473	2.38	47.7	53.5	53.7
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	228	432	1,476	1,589	1,203
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	26.1	48.9	71.5	144	159
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	26.9	49.9	115	192	206
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	202	382	1,361	1,397	997
Total Liabilities & Shareholders' Equity	228	432	1,476	1,589	1,203
Total Common Shares Outstanding